
Gliminyle MP 1mg/500mg/7.5mg Tablet
Marketer
Erinyle Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Gliminyle MP 1mg/500mg/7.5mg Tablet
Combiflex DM 1mg/500mg/7.5mg tablets offer a combined approach to managing blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex DM 1mg/500mg/7.5mg tablets. Taking it with food minimizes stomach discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or nursing individuals should also seek medical advice. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption, as this can exacerbate side effects.
Primary Ingredients of Gliminyle MP 1mg/500mg/7.5mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Gliminyle MP 1mg/500mg/7.5mg Tablet
Managing type 2 diabetes
Major Benefits of Gliminyle MP 1mg/500mg/7.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume the Gliminyle MP 1mg/500mg/7.5mg tablet with food.
Common Side effects of Gliminyle MP 1mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gliminyle MP 1mg/500mg/7.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume the Gliminyle MP 1mg/500mg/7.5mg tablet with a meal.
How Gliminyle MP 1mg/500mg/7.5mg Tablet works:
Gliminyle MP 1mg/500mg/7.5mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gliminyle MP 1mg/500mg/7.5mg tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Gliminyle MP 1mg/500mg/7.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gliminyle MP 1mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Individuals with kidney impairment should use Gliminyle MP 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The medication is contraindicated in patients exhibiting severe kidney dysfunction. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Gliminyle MP 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Gliminyle MP 1mg/500mg/7.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gliminyle MP 1mg/500mg/7.5mg Tablet :
Should you forget to take your Gliminyle MP 1mg/500mg/7.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliminyle MP 1mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
